User:Daniel Mulawa/Sandbox 1
From Proteopedia
(Difference between revisions)
Line 21: | Line 21: | ||
4 subunits | 4 subunits | ||
Nicastran (NCT),Anterior pharynx-defective 1 (APH-1), Presenilin (PS1), Presenilin enhancer 2 (PEN-2), and4 phosphatidylcholines stabilize structure (interface between PS1 and PEN-2; APH-1 and PS1; APH-1 and NCT) | Nicastran (NCT),Anterior pharynx-defective 1 (APH-1), Presenilin (PS1), Presenilin enhancer 2 (PEN-2), and4 phosphatidylcholines stabilize structure (interface between PS1 and PEN-2; APH-1 and PS1; APH-1 and NCT) | ||
- | [[Image:Ribbon structure of whole.png| | + | [[Image:Ribbon structure of whole.png|300 px|right|thumb|Figure 1]] |
[http://http://proteopedia.org/wiki/index.php/5a63 5A63 Article] | [http://http://proteopedia.org/wiki/index.php/5a63 5A63 Article] | ||
===practice=== | ===practice=== | ||
Line 39: | Line 39: | ||
===Lid Complex=== | ===Lid Complex=== | ||
- | + | ||
+ | |||
===Active Site=== | ===Active Site=== | ||
- | == Relevance | + | ==Relevance== |
APP build up leads to Amyloid plaques in brain | APP build up leads to Amyloid plaques in brain | ||
Inhibition of γ-secretase could be potential AD treatment | Inhibition of γ-secretase could be potential AD treatment |
Revision as of 20:20, 24 March 2020
Gamma Secretase
=Human Gamma Secretase=
|
References
Student Contributors
Layla Wisser Daniel Mulawa